Cumberland Pharmaceuticals (CPIX) Misses Q3 EPS by 10c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.01, $0.10 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $10.4 million versus the consensus estimate of $12.65 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Baozun Inc. (BZUN) Reports Q2 EPS of RMB0.42
• Titan Machinery (TITN) Misses Q2 EPS by 5c ; Offers Guidance